Pipeline
Therapeutic Area | Target | Product Description | Stage | Discovery | Preclinical |
---|---|---|---|---|---|
Cancer: Solid tumors | Undisclosed | Human monoclonal antibody | Preclinical | 100% | 23% |
Cancer: Solid tumors | Undisclosed | Human monoclonal antibody | Preclinical | 100% | 0% |
Infectious Disease: Covid | Undisclosed | Human monoclonal antibody | Preclinical | 100% | 0% |
Neuro-degeneration: Alzheimer’s | Undisclosed | Human monoclonal antibody | Discovery | 86% | 0% |
- ● Neurodegeneration
- ● Oncology
- ● Infectious Disease